Aptevo Therapeutics Inc. (APVO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aptevo Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.00x | -0.05x | -0.13x | 1.47x | -1.30x | -7.00x |
| P/B Ratio | 0.00x | 0.25x | 0.18x | 0.66x | 30.34x | 7.49x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 3.80x | 3.00x | 28.84x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | -314.3% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -919.7% | -174.1% | -638.1% |
| Net Margin | 0.0% | 0.0% | 0.0% | 257.8% | -231.5% | -411.9% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -890.8% | -164.8% | -607.8% |
| Liquidity | ||||||
| Current Ratio | 3.82x | 1.72x | 2.64x | 3.15x | 1.51x | 3.25x |
| Quick Ratio | 3.82x | 1.72x | 2.64x | 3.15x | 1.51x | 3.25x |
| Leverage | ||||||
| Debt/Equity | 0.27x | 0.97x | 0.44x | 0.53x | 13.75x | 1.65x |
YoY = year-over-year change. Source: FMP..